drugset / Trial / NCT01340066

Safety and Efficacy Study of a New Treatment for Symptoms of Urinary Incontinence

NCT01340066 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if a new drug treatment is effective for the treatment of symptoms of urinary incontinence.

Timeline

Start
2011-04
Primary completion
2012-05
Completion
2012-05

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Placebo vs UISH001; p = .92; Mean Difference (Final Values) 0; Chi-squared NCT01340066 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject UISH001 Unknown 1 unknown Other

Indications

No indication recorded.